71 related articles for article (PubMed ID: 29629950)
1. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
Fernandez-Pol S; Ma L; Joshi RP; Arber DA
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
[TBL] [Abstract][Full Text] [Related]
2. Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
Ye Y; Ding N; Mi L; Shi Y; Liu W; Song Y; Shu S; Zhu J
Exp Hematol Oncol; 2021 Feb; 10(1):9. PubMed ID: 33546774
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Li X
BMC Cancer; 2017 Apr; 17(1):252. PubMed ID: 28390392
[TBL] [Abstract][Full Text] [Related]
4. Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review.
Iturrate I; Loscertales J; Fernández-Ruiz E; Muñoz P; López C; Del Campo L; Muñoz C; Alegre A
Clin Case Rep; 2020 Dec; 8(12):3494-3497. PubMed ID: 33363958
[TBL] [Abstract][Full Text] [Related]
5. Mutations of epigenetic genes and correlation with treatment response in peripheral T-cell lymphoma.
Wei C; Wang W; Li W; Zhang Y; Zhao D; Zhang W; Zhou D
Clin Transl Med; 2024 Jan; 14(1):e1491. PubMed ID: 38239088
[No Abstract] [Full Text] [Related]
6. Novel insights into the pathogenesis of T-cell lymphomas.
Van Arnam JS; Lim MS; Elenitoba-Johnson KSJ
Blood; 2018 May; 131(21):2320-2330. PubMed ID: 29666117
[TBL] [Abstract][Full Text] [Related]
7. Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
Oncotarget; 2018 Mar; 9(22):16124-16133. PubMed ID: 29662631
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
Federico M; Bellei M; Marcheselli L; Schwartz M; Manni M; Tarantino V; Pileri S; Ko YH; Cabrera ME; Horwitz S; Kim WS; Shustov A; Foss FM; Nagler A; Carson K; Pinter-Brown LC; Montoto S; Spina M; Feldman TA; Lechowicz MJ; Smith SM; Lansigan F; Gabus R; Vose JM; Advani RH;
Br J Haematol; 2018 Jun; 181(6):760-769. PubMed ID: 29672827
[TBL] [Abstract][Full Text] [Related]
9. Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.
Tiacci E; Ladewig E; Schiavoni G; Penson A; Fortini E; Pettirossi V; Wang Y; Rosseto A; Venanzi A; Vlasevska S; Pacini R; Piattoni S; Tabarrini A; Pucciarini A; Bigerna B; Santi A; Gianni AM; Viviani S; Cabras A; Ascani S; Crescenzi B; Mecucci C; Pasqualucci L; Rabadan R; Falini B
Blood; 2018 May; 131(22):2454-2465. PubMed ID: 29650799
[TBL] [Abstract][Full Text] [Related]
10. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
Front Oncol; 2020; 10():898. PubMed ID: 32637355
[TBL] [Abstract][Full Text] [Related]
11. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
[TBL] [Abstract][Full Text] [Related]
12. Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant
Naganuma K; Chan A; Zhang Y; Lewis N; Xiao W; Roshal M; Dogan A; Kizaki M; Ho C; Yabe M
J Hematol; 2020 Dec; 9(4):140-146. PubMed ID: 33224395
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
Laginestra MA; Cascione L; Motta G; Fuligni F; Agostinelli C; Rossi M; Sapienza MR; Righi S; Broccoli A; Indio V; Melle F; Tabanelli V; Calleri A; Novero D; Facchetti F; Inghirami G; Sabattini E; Bertoni F; Pileri SA
Mod Pathol; 2020 Feb; 33(2):179-187. PubMed ID: 31028364
[TBL] [Abstract][Full Text] [Related]
15. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
16. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes.
Huang YH; Qiu YR; Zhang QL; Cai MC; Yu H; Zhang JM; Jiang L; Ji MM; Xu PP; Wang L; Cheng S; Zhao WL
Cell Rep Med; 2024 Feb; 5(2):101416. PubMed ID: 38350451
[TBL] [Abstract][Full Text] [Related]
17. The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas.
Tigu AB; Bancos A
Curr Issues Mol Biol; 2023 Nov; 45(11):8974-8988. PubMed ID: 37998740
[TBL] [Abstract][Full Text] [Related]
18. Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.
Shi Y; Wang H; Liu Y; Long M; Ding N; Mi L; Lai Y; Zhou L; Diao X; Li X; Liu W; Zhu J
Chin J Cancer Res; 2023 Oct; 35(5):536-549. PubMed ID: 37969960
[TBL] [Abstract][Full Text] [Related]
19. Targeting
Hu L; Zhang X; Li H; Lin S; Zang S
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428791
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
